The impact of HIV-1 on neurogenesis: Implications for HAND

Cellular and Molecular Life Sciences

Volumn 71, Issue 22, 2014, Pages 4387-4392

  Ferrell, Darren ^a   Giunta, Brian ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cognitive; gp120; Hippocampus; HIV; Neurogenesis; Tat

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN; GLYCOPROTEIN GP 120; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN ATROPHY; COGNITIVE DEFECT; DISEASE ASSOCIATION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; REVIEW; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; NEURODEGENERATIVE DISEASES; PATHOPHYSIOLOGY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

AMYLOID BETA-PEPTIDES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; NEURODEGENERATIVE DISEASES; NEUROGENESIS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84925284551     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1702-4     Document Type: Review

References (51)

1. Lima VD et al (2007) Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS 21(6):685-692
2. Quashie PK, Mesplede T, Wainberg MA (2013) HIV drug resistance and the advent of integrase inhibitors. Curr Infect Dis Rep 15(1):85-100
3. Lieberman-Blum SS, Fung HB, Bandres JC (2008) Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection. Clin Ther 30(7):1228-1250
4. Del Guerra FB et al (2013) Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. J Neurovirol 19(4):314-327
5. Ances BM, Ellis RJ (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27(1):86-92
6. Adle-Biassette H et al (1995) Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 21(3):218-227
7. Okamoto S et al (2007) HIV/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest. Cell Stem Cell 1(2):230-236
8. Thomas S, Mayer L, Sperber K (2009) Mitochondria influence Fas expression in gp120-induced apoptosis of neuronal cells. Int J Neurosci 119(2):157-165
9. Kruman II, Nath A, Mattson MP (1998) HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154(2):276-288
10. Vissers M, Stelma FF, Koopmans PP (2010) Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system? J Clin Virol 49(4):231-238
11. Apostolova N, Blas-Garcia A, Esplugues JV (2011) Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-gamma inhibition. Trends Pharmacol Sci 32(12):715-725
12. Apostolova N, Blas-Garcia A, Esplugues JV (2011) Mitochondrial toxicity in HAART: an overview of in vitro evidence. Curr Pharm Des 17(20):2130-2144
13. Apostolova N et al (2011) Compromising mitochondrial function with the antiretroviral drug efavirenz induces cell survival-promoting autophagy. Hepatology 54(3):1009-1019
14. Zhou L, Saksena NK (2013) HIV associated neurocognitive disorders. Infect Dis Rep 5(Suppl 1):e8
15. Blas-Garcia A, Apostolova N, Esplugues JV (2011) Oxidative stress and mitochondrial impairment after treatment with anti-HIV drugs: clinical implications. Curr Pharm Des 17(36):4076-4086
16. Blas-Garcia A, Esplugues JV, Apostolova N (2011) Twenty years of HIV-1 non-nucleoside reverse transcriptase inhibitors: time to reevaluate their toxicity. Curr Med Chem 18(14):2186-2195
17. Brown LA et al (2014) Efavirenz promotes beta-secretase expression and increased Abeta1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND). PLoS One 9(4):e95500
18. Giunta B et al (2011) Antiretroviral medications disrupt microglial phagocytosis of beta-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain 4(1):23
19. Manda KR et al (2011) Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells. Free Radic Biol Med 50(7):801-810
20. Akay C et al (2014) Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J Neurovirol 20(1):39-53
21. Alfahad TB, Nath A (2013) Update on HIV-associated neurocognitive disorders. Curr Neurol Neurosci Rep 13(10):387
22. Rosca EC et al (2012) HIV-associated neurocognitive disorders: a historical review. Neurologist 18(2):64-67
23. Snider WD et al (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14(4):403-418
24. Navia BA, Price RW (1987) The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol 44(1):65-69
25. (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41(6): 778-785
26. Antinori A et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789-1799
27. Lacar B et al (2014) Increasing the resolution of the adult neurogenesis picture. F1000 Prime Rep 6:8
28. Gage FH, Temple S (2013) Neural stem cells: generating and regenerating the brain. Neuron 80(3):588-601
29. Green HF, Nolan YM (2014) Inflammation and the developing brain: consequences for hippocampal neurogenesis and behavior. Neurosci Biobehav Rev 40C:20-34
30. Frisoni GB et al (2008) Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla. Brain 131(Pt 12):3266-3276
31. Kempermann G, Kuhn HG, Gage FH (1997) More hippocampal neurons in adult mice living in an enriched environment. Nature 386(6624):493-495
32. Schinder AF, Gage FH (2004) A hypothesis about the role of adult neurogenesis in hippocampal function. Physiology (Bethesda) 19:253-261
33. Peng H et al (2008) HIV-1-infected and/or immune-activated macrophage-secreted TNF-alpha affects human fetal cortical neural progenitor cell proliferation and differentiation. Glia 56(8):903-916
34. Tamamis P, Floudas CA (2013) Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop. Biophys J 105(6):1502-1514
35. Bagri A et al (2002) The chemokine SDF1 regulates migration of dentate granule cells. Development 129(18):4249-4260
36. Kaul M (2008) HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis. Front Biosci 13:2484-2494
37. Lawrence DM et al (2004) Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J Virol 78(14):7319-7328
38. Schwartz L et al (2007) Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue. J Neurovirol 13(3):274-283
39. Krathwohl MD, Kaiser JL (2004) HIV-1 promotes quiescence in human neural progenitor cells. J Infect Dis 190(2):216-226
40. Mishra M et al (2010) Human immunodeficiency virus type 1 Tat modulates proliferation and differentiation of human neural precursor cells: implication in NeuroAIDS. J Neurovirol 16(5):355-367
41. Lee MH et al (2011) Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease. Neurobiol Dis 41(3):678-687
42. Das S, Basu A (2011) Viral infection and neural stem/progenitor cell's fate: implications in brain development and neurological disorders. Neurochem Int 59(3):357-366
43. Peng H et al (2011) HIV-1-infected and immune-activated macrophages induce astrocytic differentiation of human cortical neural progenitor cells via the STAT3 pathway. PLoS One 6(5):e19439
44. Yao H et al (2012) Platelet-derived growth factor-BB restores human immunodeficiency virus Tat-cocaine-mediated impairment of neurogenesis: role of TRPC1 channels. J Neurosci 32(29):9835-9847
45. Gorantla S et al (2007) Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis. J Immunol 179(7):4345-4356
46. Geffin R et al (2013) Apolipoprotein E-dependent differences in innate immune responses of maturing human neuroepithelial progenitor cells exposed to HIV-1. J Neuroimmune Pharmacol 8(4):1010-1026
47. Mocchetti I et al (2014) Implementing neuronal plasticity in neuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors. J Neuroimmune Pharmacol 9(2):80-91
48. Lee MH et al (2013) Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation. J Neurovirol 19(5):418-431
49. Yang L et al (2013) Involvement of miR-9/MCPIP1 axis in PDGF-BB-mediated neurogenesis in neuronal progenitor cells. Cell Death Dis 4:e960
50. Chao J et al (2014) Platelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-3beta/beta-catenin. J Neuroimmune Pharmacol 9(2):259-268
51. Avraham HK et al (2014) Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme. Br J Pharmacol. doi: 10.1111/bph.12657